Assertio Holdings, Inc. (ASRT)
NASDAQ: ASRT · Real-Time Price · USD
11.64
0.00 (0.00%)
Jan 23, 2026, 9:30 AM EST - Market open
Assertio Holdings Employees
Assertio Holdings had 58 employees as of December 31, 2024. The number of employees increased by 5 or 9.43% compared to the previous year.
Employees
58
Change (1Y)
5
Growth (1Y)
9.43%
Revenue / Employee
$2,368,172
Profits / Employee
-$498,690
Market Cap
74.69M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 58 | 5 | 9.43% |
| Dec 31, 2023 | 53 | 23 | 76.67% |
| Dec 31, 2022 | 30 | 11 | 57.89% |
| Dec 31, 2021 | 19 | -8 | -29.63% |
| Dec 31, 2020 | 27 | -98 | -78.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 320 |
| Anika Therapeutics | 288 |
| Zhengye Biotechnology Holding | 277 |
| Rockwell Medical | 244 |
| Alpha Teknova | 173 |
| Cumberland Pharmaceuticals | 91 |
| BioXcel Therapeutics | 37 |
| Cardiol Therapeutics | 18 |
ASRT News
- 10 days ago - Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements - Business Wire
- 13 days ago - Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial - Business Wire
- 4 weeks ago - Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split - Business Wire
- 2 months ago - Assertio Holdings, Inc. (ASRT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Assertio Reports Third Quarter 2025 Financial Results - Business Wire
- 3 months ago - Assertio Announces Leadership Transition - GlobeNewsWire
- 4 months ago - DEADLINE NEXT WEEK: Berger Montague Advises Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors to Contact the Firm Before September 24, 2025 - GlobeNewsWire
- 4 months ago - Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV - GlobeNewsWire